Semler Scientific, a publicly traded healthcare technology firm, has made headlines by acquiring an additional $50 million in Bitcoin, raising its total holdings to approximately $466 million. This move aligns with the company’s strategy to pivot towards becoming a Bitcoin treasury. However, Semler faces scrutiny from Bragar Eagel & Squire, a law firm investigating the company for potential violations of federal securities laws and other unlawful business practices. The firm has invited shareholders who have suffered losses to come forward. The investigation adds to existing challenges for Semler, which has been under review by the U.S. Department of Justice regarding the reimbursement claims related to its QuantaFlo device. Since 2017, the DOJ has been looking into the company, including multiple follow-ups in subsequent years. Despite these legal difficulties, Semler's stock remains active, trading at $44.20, although it has seen a slight decline amid these developments.

Source 🔗